Spirituality has been hinted to boost patient outcomes, although it hasn't been thoroughly tested in clinical trials yet. Imagine this: a condition like hypertension, a leading cause of heart disease globally, might be influenced by something other than medications. Enter the FEEL Trial, which delve
Psychedelics have been part of human culture for centuries, with strong links to spiritual practices. Now, scientists are exploring their potential to heal mental health issues like PTSD, depression, and anxiety. These drugs work by changing how brain areas communicate with each other, making the br
Imagine you're trying to find a solution to a big problem, like cancer. To make sure your solution works for everyone, you need people from all walks of life to test it out. But sometimes, certain groups are left out. That's exactly what happens in clinical trials. The NHS-Galleri trial is trying t
Imagine you’ve just had a heart procedure and your doctor wants to know how you're feeling. Instead of waiting for your appointment, you can now share your health journey directly. This is what electronic patient-reported outcome (PRO) systems aim to do in outpatient cardiovascular care. While that
Imagine you're running a clinical trial to test a new treatment in critical care. You're tracking how patients do after the treatment, but what if some patients don't make it long enough to see the full results? That's what we're calling "truncation due to death. " The big question is, how do we han
Every year, over 60 million people face traumatic brain injuries (TBIs), leading to significant health issues and even death. Managing these injuries is tough, with a heavy toll on individuals and society. For the past couple of decades, there's been a rise in clinical trials focusing on neurocriti
Meet rimegepant, a new drug that blocks certain signals in your brain to stop migraines. It's been tested in labs and found to work, but what about in the real world? That's what the GAINER study set out to find. This study, happening in multiple places, looked at how well rimegepant works and how t
Immune-checkpoint inhibitors (ICIs) have emerged as a powerful tool in the fight against advanced squamous cell lung cancer (LUSC). These drugs offer a glimmer of hope for patients who haven't found success with other treatments. But it's not a one-size-fits-all solution—some patients don't respond
Imagine you're missing a tooth and the bone around that area needs help to grow back. Would you rather have a membrane made of gelatin and polylactic acid (GT/PLA) or one called Guidor®? This experiment involved 32 people who needed bone regrowth after losing a tooth. They were split into two groups
Psoriatic arthritis, or PsA, is a complex inflammatory disease that can affect joints and skin, and it often comes with other health issues. Managing PsA is crucial to control the disease, prevent damage, and improve quality of life. Over time, many drugs have been developed to help. While some, lik
